American Century Companies’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
Other funds holding BVS
EWM
JIC
NCM
VCM
RA
VPM
American Century Companies's BVS Position: Q1 2026 in Review
American Century Companies reduced its Bioventus (BVS) stake by 27% in Q1 2026, selling an estimated $1.91M and leaving 619,803 shares worth $5.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1722.
American Century Companies first reported a position in BVS in Q1 2023 and has held it in 13 quarters since. The position peaked at $9.55M in Q1 2025. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.
- American Century Companies held 619,803 shares of Bioventus worth $5.66M as of Q1 2026.
- American Century Companies sold 227,988 Bioventus shares in Q1 2026, an estimated $1.91M.
- Bioventus made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #1722 holding.
- American Century Companies first reported a position in Bioventus in Q1 2023 and has held it in 13 quarters since.
- American Century Companies's Bioventus position peaked at $9.55M in Q1 2025.
- 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.